Artivion, Inc.
AORTNYSEHealthcare● Active
$20.39
+$0.27(+1.34%)
Market Cap$989797887
P/E Ratio—
52W High$48.25
52W Low$19.16
Artivion, Inc. (AORT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AORT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.08
Est. $0.06 · +33.3%
Revenue
$0.12B
Est. $0.12B · +0.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS🔥 4-Quarter EPS Beat Streak
AORT reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.13 | — | — | — | $0.12B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.06 | $0.08 | +33.3% | $0.12B | $0.12B | +0.6% |
| ▲ Q1 FY2026 | Feb 12, 2026 | $0.14 | $0.17 | +21.4% | $0.12B | $0.12B | -0.4% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.14 | $0.16 | +14.3% | $0.11B | $0.12B | -2.6% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.11 | $0.24 | +118.2% | $0.11B | $0.11B | +5.1% |
| ▼ Q2 FY2025 | May 5, 2025 | $0.12 | $0.06 | -50.0% | $0.10B | $0.11B | -8.8% |
| ▼ Q1 FY2025 | Feb 24, 2025 | $0.12 | -$0.39 | -425.0% | $0.10B | $0.10B | -3.5% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.10 | $0.12 | +20.6% | $0.10B | $0.10B | -5.3% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.13
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.08
EPS Est.
$0.06
EPS Surpr.
+33.3%
Revenue
$0.12B
Q1 FY2026
Feb 12, 2026Beat
EPS Actual
$0.17
EPS Est.
$0.14
EPS Surpr.
+21.4%
Revenue
$0.12B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.16
EPS Est.
$0.14
EPS Surpr.
+14.3%
Revenue
$0.11B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.24
EPS Est.
$0.11
EPS Surpr.
+118.2%
Revenue
$0.11B
Q2 FY2025
May 5, 2025Miss
EPS Actual
$0.06
EPS Est.
$0.12
EPS Surpr.
-50.0%
Revenue
$0.10B
Q1 FY2025
Feb 24, 2025Miss
EPS Actual
-$0.39
EPS Est.
$0.12
EPS Surpr.
-425.0%
Revenue
$0.10B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.12
EPS Est.
$0.10
EPS Surpr.
+20.6%
Revenue
$0.10B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.22 | $0.23 | $0.24 | 1 |
| Q3 FY2028 | $0.19 | $0.20 | $0.21 | 1 |
| Q2 FY2028 | $0.17 | $0.18 | $0.19 | 1 |
| Q1 FY2028 | $0.14 | $0.14 | $0.14 | 1 |
| Q4 FY2027 | $0.16 | $0.17 | $0.17 | 1 |
| Q3 FY2027 | $0.11 | $0.12 | $0.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2028 | $0.1B | $0.2B | $0.2B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.2B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +33.3% | $34.73 | $35.42 | +1.99% |
| ▲ Q1 FY2026 | Feb 12, 2026 | +21.4% | $40.10 | $40.65 | +1.37% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +14.3% | $46.51 | $47.50 | +2.13% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +118.2% | $32.27 | $32.70 | +1.33% |
| ▼ Q2 FY2025 | May 5, 2025 | -50.0% | $23.33 | $23.77 | +1.89% |
| ▼ Q1 FY2025 | Feb 24, 2025 | -425.0% | $28.26 | $27.85 | -1.45% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +20.6% | $29.44 | $28.98 | -1.56% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +114.3% | $25.15 | $25.33 | +0.72% |
Q2 FY2026+1.99%
Report Date
May 7, 2026
EPS Beat/Miss
+33.3%
Price Before
$34.73
Price After
$35.42
Q1 FY2026+1.37%
Report Date
Feb 12, 2026
EPS Beat/Miss
+21.4%
Price Before
$40.10
Price After
$40.65
Q4 FY2025+2.13%
Report Date
Nov 6, 2025
EPS Beat/Miss
+14.3%
Price Before
$46.51
Price After
$47.50
Q3 FY2025+1.33%
Report Date
Aug 7, 2025
EPS Beat/Miss
+118.2%
Price Before
$32.27
Price After
$32.70
Q2 FY2025+1.89%
Report Date
May 5, 2025
EPS Beat/Miss
-50.0%
Price Before
$23.33
Price After
$23.77
Q1 FY2025-1.45%
Report Date
Feb 24, 2025
EPS Beat/Miss
-425.0%
Price Before
$28.26
Price After
$27.85
Q4 FY2024-1.56%
Report Date
Nov 7, 2024
EPS Beat/Miss
+20.6%
Price Before
$29.44
Price After
$28.98
Q3 FY2024+0.72%
Report Date
Aug 8, 2024
EPS Beat/Miss
+114.3%
Price Before
$25.15
Price After
$25.33
Avg Beat Reaction+1.00%
Avg Miss Reaction+0.22%
Beat Rate6 / 8 quarters
Largest Move+2.13% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AORT ends December
Artivion, Inc. (AORT) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.08 — beating the analyst consensus of $0.06 by +33.3%. AORT has beaten EPS estimates for 4 consecutive quarters. The next AORT earnings date is expected around September 1, 2026.
Each quarter, investors track AORT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AORT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AORT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AORT earnings · 5 questionsArtivion, Inc.'s next earnings report is expected around September 1, 2026. AORT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AORT historically reports after market close (AMC).
AORT earnings datewhen is AORT earningsAORT next earnings datewhen does AORT report earningsAORT earnings calendar
▸ Source: FMP · Artivion, Inc. SEC filings · US GAAP · Artivion, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026